Edward B. Arenson

816 total citations
24 papers, 617 citations indexed

About

Edward B. Arenson is a scholar working on Genetics, Oncology and Hematology. According to data from OpenAlex, Edward B. Arenson has authored 24 papers receiving a total of 617 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 7 papers in Oncology and 6 papers in Hematology. Recurrent topics in Edward B. Arenson's work include Glioma Diagnosis and Treatment (5 papers), Neuroblastoma Research and Treatments (5 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Edward B. Arenson is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), Neuroblastoma Research and Treatments (5 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Edward B. Arenson collaborates with scholars based in United States, United Kingdom and France. Edward B. Arenson's co-authors include Robert C. Seeger, Michael Epstein, Alan Tesler, Richard E. Champlin, Stephen A. Feig, Marilyn Stern, Paul S. Lietman, Charles S. August, Robert Peter Gale and Jeffrey C. Allen and has published in prestigious journals such as JAMA, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Edward B. Arenson

24 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edward B. Arenson United States 15 224 223 113 104 101 24 617
Gavivann Veerakul Thailand 14 163 0.7× 238 1.1× 61 0.5× 132 1.3× 177 1.8× 34 744
F Freyçon France 18 170 0.8× 241 1.1× 115 1.0× 181 1.7× 202 2.0× 117 1.1k
Jochen Heymanns Germany 20 257 1.1× 135 0.6× 243 2.2× 311 3.0× 114 1.1× 63 994
E. S. Henderson United States 17 226 1.0× 352 1.6× 176 1.6× 304 2.9× 102 1.0× 33 909
Fuensanta Millá Spain 15 369 1.6× 524 2.3× 109 1.0× 219 2.1× 112 1.1× 78 980
Roger Brearley United Kingdom 12 228 1.0× 203 0.9× 85 0.8× 266 2.6× 43 0.4× 22 775
Pascale Schneider France 14 125 0.6× 252 1.1× 119 1.1× 166 1.6× 394 3.9× 58 921
S. J. Lee United States 17 170 0.8× 517 2.3× 119 1.1× 192 1.8× 37 0.4× 22 794
Elisabeth Reiter Austria 13 96 0.4× 344 1.5× 117 1.0× 74 0.7× 70 0.7× 34 532
Annalisa Serra Italy 14 86 0.4× 134 0.6× 52 0.5× 80 0.8× 164 1.6× 47 520

Countries citing papers authored by Edward B. Arenson

Since Specialization
Citations

This map shows the geographic impact of Edward B. Arenson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward B. Arenson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward B. Arenson more than expected).

Fields of papers citing papers by Edward B. Arenson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward B. Arenson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward B. Arenson. The network helps show where Edward B. Arenson may publish in the future.

Co-authorship network of co-authors of Edward B. Arenson

This figure shows the co-authorship network connecting the top 25 collaborators of Edward B. Arenson. A scholar is included among the top collaborators of Edward B. Arenson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward B. Arenson. Edward B. Arenson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Sun, Xiaowu, et al.. (2020). PNS213 Dimensional Structure of Dermatology Life Quality Index in Patients with Atopic Dermatitis: Bifactor Model Approach. Value in Health. 23. S676–S677. 1 indexed citations
3.
Mechtler, Laszlo, Lawrence D. Recht, Nina A. Paleologos, et al.. (2007). The effect of corticorelin acetate on peritumoral brain edema: An interim report of an open-label study as part of a phase III program. Journal of Clinical Oncology. 25(18_suppl). 9095–9095. 1 indexed citations
4.
MacDonald, Tobey J., Edward B. Arenson, Joann L. Ater, et al.. (2005). Phase II study of high‐dose chemotherapy before radiation in children with newly diagnosed high‐grade astrocytoma. Cancer. 104(12). 2862–2871. 44 indexed citations
5.
Jakacki, Regina I., Bruce H. Cohen, Cheryl Sorenson Jamison, et al.. (2000). Phase II evaluation of interferon α-2a for progressive or recurrent craniopharyngiomas. Journal of neurosurgery. 92(2). 255–260. 53 indexed citations
6.
Arenson, Edward B., Joann L. Ater, Janet Bruner, et al.. (1999). #416 A randomized phase II trial of high dose alkylating agents plus VP-16 in children with high grade astrocytoma. Journal of Pediatric Hematology/Oncology. 21(4). 325–325. 5 indexed citations
7.
Foreman, Nicholas K., et al.. (1999). Health Status in 52 Long-term Survivors of Pediatric Brain Tumors. Journal of Neuro-Oncology. 41(1). 47–53. 53 indexed citations
8.
Krystosek, Alphonse, et al.. (1994). Reverse Transformation and Genome Exposure in the C6 Glial Tumor Cell Line. Cancer Investigation. 12(1). 33–45. 12 indexed citations
9.
Lange, Beverly J., Susana C. Raimondi, NA Heerema, et al.. (1992). Pediatric leukemia/lymphoma with t(8;14)(q24;q11).. PubMed. 6(7). 613–8. 25 indexed citations
10.
Allen, Jeffrey C., et al.. (1992). Choroid plexus carcinoma ? responses to chemotherapy alone in newly diagnosed young children. Journal of Neuro-Oncology. 12(1). 69–74. 49 indexed citations
11.
Arenson, Edward B., et al.. (1989). Bone marrow transplantation for acute leukemia and down syndrome: Report of a successful case and results of a national survey. The Journal of Pediatrics. 114(1). 69–72. 25 indexed citations
12.
Stern, Marilyn & Edward B. Arenson. (1989). Childhood Cancer Stereotype: Impact on Adult Perceptions of Children. Journal of Pediatric Psychology. 14(4). 593–605. 28 indexed citations
13.
Hall, C, R H Lindenbaum, Edward B. Arenson, J. A. Begley, & Richard C. Chu. (1989). The nature of the defect in cobalamin G mutation.. PubMed. 12(4). 262–9. 16 indexed citations
14.
Feig, Stephen A., Richard E. Champlin, Edward B. Arenson, et al.. (1983). Improved survival following bone marrow transplantation for aplastic anaemia. British Journal of Haematology. 54(4). 509–517. 50 indexed citations
15.
Feig, Stephen A., Richard E. Champlin, Edward B. Arenson, et al.. (1983). Improved survival following bone marrow transplantation for aplastic anaemia. British Journal of Haematology. 54(4). 509–517. 29 indexed citations
16.
Arenson, Edward B., Michael Epstein, & Robert C. Seeger. (1980). Volumetric and functional heterogeneity of human monocytes.. Journal of Clinical Investigation. 65(3). 613–618. 49 indexed citations
17.
Arenson, Edward B., et al.. (1979). Monocyte subsets in neonates and children.. PubMed. 64(5 Pt 2 Suppl). 740–4. 12 indexed citations
18.
Arenson, Edward B.. (1976). Neuroblastoma in Father and Son. JAMA. 235(7). 727–727. 15 indexed citations
19.
Arenson, Edward B.. (1976). Neuroblastoma in father and son. JAMA. 235(7). 727–729. 3 indexed citations
20.
Lietman, Paul S., Edward B. Arenson, & Charles S. August. (1975). Preliminary report: Treatment of the hemolytic-uremic syndrome with aspirin and dipyridamole. The Journal of Pediatrics. 86(6). 957–961. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026